Form 4: Amylyx Pharmaceuticals Chief Legal Officer Sells Shares to Cover Tax Obligations

Gina Mazzariello, Chief Legal Officer of Amylyx Pharmaceuticals, sold 9,192 shares of common stock on March 31, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 31, 2025, Gina Mazzariello, the Chief Legal Officer of Amylyx Pharmaceuticals, sold 9,192 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $3.4763, with individual transactions ranging from $3.44 to $3.58.
• Following the transaction, Mazzariello directly owns 187,969 shares of Amylyx Pharmaceuticals.
• The sale was automatic and not at the discretion of the reporting person.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, not indicative of a major shift in sentiment towards the company.

Industry Context

This is a routine transaction related to insider selling to cover tax obligations, which is a common occurrence in publicly traded companies. It doesn't necessarily reflect a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a company officer could have a minor impact on shareholder confidence, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Amylyx Pharmaceuticals, Gina Mazzariello, insider trading, Form 4, stock sale, tax withholding, restricted stock units, AMLX